It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AZTA’s FA Score shows that 0 FA rating(s) are green whileNEPH’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AZTA’s TA Score shows that 5 TA indicator(s) are bullish while NEPH’s TA Score has 3 bullish TA indicator(s).
AZTA (@Pharmaceuticals: Other) experienced а +0.75% price change this week, while NEPH (@Pharmaceuticals: Other) price change was -19.86% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.62%. For the same industry, the average monthly price growth was +0.12%, and the average quarterly price growth was +6.19%.
AZTA is expected to report earnings on Nov 18, 2025.
NEPH is expected to report earnings on Mar 05, 2026.
Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
| AZTA | NEPH | AZTA / NEPH | |
| Capitalization | 1.37B | 47.1M | 2,913% |
| EBITDA | 11.3M | 1.49M | 756% |
| Gain YTD | -38.460 | 210.204 | -18% |
| P/E Ratio | N/A | 31.64 | - |
| Revenue | 669M | 16.7M | 4,006% |
| Total Cash | 319M | 5.07M | 6,287% |
| Total Debt | 52.6M | 1.24M | 4,239% |
AZTA | NEPH | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 15 | 77 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 64 Fair valued | 65 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 93 | 54 | |
PRICE GROWTH RATING 1..100 | 59 | 38 | |
P/E GROWTH RATING 1..100 | 45 | 99 | |
SEASONALITY SCORE 1..100 | 90 | 27 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
AZTA's Valuation (64) in the Electronic Production Equipment industry is in the same range as NEPH (65) in the null industry. This means that AZTA’s stock grew similarly to NEPH’s over the last 12 months.
AZTA's Profit vs Risk Rating (100) in the Electronic Production Equipment industry is in the same range as NEPH (100) in the null industry. This means that AZTA’s stock grew similarly to NEPH’s over the last 12 months.
NEPH's SMR Rating (54) in the null industry is somewhat better than the same rating for AZTA (93) in the Electronic Production Equipment industry. This means that NEPH’s stock grew somewhat faster than AZTA’s over the last 12 months.
NEPH's Price Growth Rating (38) in the null industry is in the same range as AZTA (59) in the Electronic Production Equipment industry. This means that NEPH’s stock grew similarly to AZTA’s over the last 12 months.
AZTA's P/E Growth Rating (45) in the Electronic Production Equipment industry is somewhat better than the same rating for NEPH (99) in the null industry. This means that AZTA’s stock grew somewhat faster than NEPH’s over the last 12 months.
| AZTA | NEPH | |
|---|---|---|
| RSI ODDS (%) | N/A | 7 days ago 79% |
| Stochastic ODDS (%) | 2 days ago 69% | 2 days ago 79% |
| Momentum ODDS (%) | 2 days ago 73% | 2 days ago 80% |
| MACD ODDS (%) | 2 days ago 86% | 2 days ago 76% |
| TrendWeek ODDS (%) | 2 days ago 70% | 2 days ago 79% |
| TrendMonth ODDS (%) | 2 days ago 75% | 2 days ago 77% |
| Advances ODDS (%) | 2 days ago 70% | 2 days ago 77% |
| Declines ODDS (%) | 7 days ago 84% | 4 days ago 79% |
| BollingerBands ODDS (%) | N/A | 2 days ago 76% |
| Aroon ODDS (%) | 2 days ago 80% | 2 days ago 77% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| LIFEX | 18.18 | 0.13 | +0.72% |
| Domini Sustainable Solutions Ins | |||
| PCPAX | 23.72 | 0.14 | +0.59% |
| PACE Large Co Value Equity A | |||
| BRMIX | 16.17 | 0.03 | +0.19% |
| iShares Russell Mid-Cap Index Instl | |||
| BERIX | 14.23 | 0.02 | +0.14% |
| Carillon Chartwell Real Income I | |||
| ODVIX | 48.25 | 0.03 | +0.06% |
| Invesco Developing Markets R6 | |||
A.I.dvisor indicates that over the last year, AZTA has been loosely correlated with IQV. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if AZTA jumps, then IQV could also see price increases.
| Ticker / NAME | Correlation To AZTA | 1D Price Change % | ||
|---|---|---|---|---|
| AZTA | 100% | +0.36% | ||
| IQV - AZTA | 60% Loosely correlated | +1.08% | ||
| RVTY - AZTA | 59% Loosely correlated | -0.19% | ||
| A - AZTA | 59% Loosely correlated | +1.41% | ||
| MTD - AZTA | 59% Loosely correlated | +0.19% | ||
| BRKR - AZTA | 58% Loosely correlated | +1.82% | ||
More | ||||
A.I.dvisor indicates that over the last year, NEPH has been loosely correlated with SGHT. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if NEPH jumps, then SGHT could also see price increases.
| Ticker / NAME | Correlation To NEPH | 1D Price Change % | ||
|---|---|---|---|---|
| NEPH | 100% | +5.31% | ||
| SGHT - NEPH | 34% Loosely correlated | +9.66% | ||
| IMDX - NEPH | 31% Poorly correlated | +12.69% | ||
| GH - NEPH | 28% Poorly correlated | +0.13% | ||
| AZTA - NEPH | 25% Poorly correlated | +0.36% | ||
| NEO - NEPH | 24% Poorly correlated | -4.03% | ||
More | ||||